Pfizer will merge its off-patent drug business with generic drugmaker Mylan, a move that would create a lower-priced medication powerhouse, according to The Wall Street Journal.

Health clinics planning to leave the federal family planning program for low-income Americans may have to destroy or return tens of thousands of worth of drugs, including contraceptives and intrauterine devices, Politico reports.

Herbal Doctor Remedies has recalled 43 products due to unsafe manufacturing practices and marketing without FDA approval.

The Senate Finance Committee advanced a sweeping bipartisan bill to address prescription drug pricing in the U.S. on July 25, according to STAT news. 

Merck plans to lay off 150 full-time employees in Durham, N.C., as the drugmaker moves production of varicella, the active ingredient used in chickenpox and shingles vaccines, outside the state, according to The News & Observer. 

Four drugs or medical devices approved by the FDA since July 19:

Climate change, expected to make several deadly tropical diseases more widespread, will create a business opportunity for some pharmaceutical companies, according to a Morgan Stanley research note cited by Business Insider.

The White House earlier in July scrapped a proposal to ban drug rebates, but a Senate panel wants to resurrect the ban in the final version of its drug-pricing bill, according to CNBC.

The FDA has approved Eli Lilly's treatment for severe hypoglycemia, the first emergency treatment that can be administered without an injection.

President Donald Trump met with pharmaceutical executives at the White House this week, according to The Hill.